ANATOMY OF A FAILURE TO LAUNCH: BARRIERS TO GENERIC MARKET ENTRY AND THE USE OF COMPETITION LAW AS A REMEDY
Section
Health & Consumers
Event Description
The webinar will be the occasion for the launch of a White Paper entitled “Anatomy of a failure to launch: A review of barriers to generic and biosimilar entry and the use of competition law”.
The discussion will focus on how to make sure that current barriers to generic and biosimilar medicines market entry can be tackled in order to avoid any unnecessary delays to patient access.
The launch of the White Paper aims to inform the current debate around the IP strategy in the context of the broader Pharmaceutical Strategy of the European Commission. Discussions will include how to deal with IP and patent quality, patent linkage, pricing strategies, as well as ways to ensure effective competition in the pharmaceutical market.
Events of the week
Jobs
International Dairy Federation
Bee Life Europe
Euractiv
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Circular Bio-based Europe Joint Undertaking (CBE JU)
COCIR
Euractiv
Euractiv
EURACTIV News
- US stops UN from recognizing a Palestinian state through membership
- Bulgaria likely won’t join eurozone in January 2025 despite government goal
- Two Polish ex-ministers sentenced for abuse of power to run for MEP seats
- EU sees signs China supplying dual-use components to Russia, Dombrovskis says
- Czech lawmakers’ debate on EU migration gets heated, draws attention of Commissioner